Get started
Author

Judith Dalmau

Observed names: Dalmau Judith, Dalmau, Judith, J Dalmau, J. Dalmau, Judit Dalmau, Judith Dalmau Moreno
Institution: IrsiCaixa
Observed institutions: University of Bern, Universidad Complutense de Madrid, Universitat Autònoma de Barcelona, University Hospital of Bern, Instituto de Salud Carlos III, IrsiCaixa, Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol, University of Lausanne
ORCID: 0000-0001-7513-3711
Observed ORCID: 0000-0001-7513-3711
OpenAlex ID: A5050335754
Common Genetic Variation and the Control of HIV-1 in Humans
2009 · Jacques Fellay, Dongliang Ge, et al. · PLoS Genetics · 446
PDF
Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells
2014 · Maria J. Buzon, Enrique Martin-Gayo, et al. · Journal of Virology · 292
PDF
A Dendritic Cell–Based Vaccine Elicits T Cell Responses Associated with Control of HIV-1 Replication
2013 · Felipe García, Nuria Climent, et al. · Science Translational Medicine · 227
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control
2013 · István Bartha, Jonathan M Carlson, et al. · eLife · 200
Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque
2011 · Margalida Rotger, Judith Dalmau, et al. · Journal of Clinical Investigation · 198
Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load
2015 · Paul J. McLaren, Cedric Coulonges, et al. · Proceedings of the National Academy of Sciences · 185
PDF
Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls
2013 · Paul J. McLaren, Cédric Coulonges, et al. · PLoS Pathogens · 155
PDF
A Therapeutic Dendritic Cell-Based Vaccine for HIV-1 Infection
2011 · Felipe García, Núria Climent, et al. · The Journal of Infectious Diseases · 137
PDF
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection
2020 · Maria Gonzalez-Cao, Teresa Morán, et al. · JAMA Oncology · 110
PDF
HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells
2015 · Maria Pino, Itziar Erkizia, et al. · Retrovirology · 102
PDF
Post COVID-19 Condition in Children and Adolescents: An Emerging Problem
2022 · Jon Izquierdo-Pujol, Sara Moron-Lopez, et al. · Frontiers in Pediatrics · 88
PDF
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption
2020 · Viviane M. Andrade, Carla Mavian, et al. · Proceedings of the National Academy of Sciences · 75
Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART
2011 · Maria J. Buzón, Francisco M. Codoñer, et al. · PLoS Pathogens · 61
PDF
Contribution of Immunological and Virological Factors to Extremely Severe Primary HIV Type 1 Infection
2008 · Judith Dalmau, Maria Carmen Puertas, et al. · Clinical Infectious Diseases · 47
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A
2013 · J. Lane, P. J. McLaren, et al. · Human Molecular Genetics · 44
PDF
Identification of Siglec-1 null individuals infected with HIV-1
2016 · Javier Martinez-Picado, Paul J. McLaren, et al. · Nature Communications · 43
PDF
The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates
2009 · Maria José Buzón, Judith Dalmau, et al. · AIDS · 37
Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab
2019 · Oscar Blanch-Lombarte, Cristina Gálvez, et al. · Journal of Clinical Medicine · 29
PDF
Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study
2024 · Maria Salgado, Cristina Gálvez, et al. · The Lancet HIV · 28
PDF
Differential Immunodominance Hierarchy of CD8+T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection
2017 · Emily Adland, Matilda Hill, et al. · Journal of Virology · 28
PDF
Extremely low viral reservoir in treated chronically HIV-1-infected individuals
2020 · Cristina Gálvez, Victor Urrea, et al. · EBioMedicine · 26
PDF
Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles
2021 · Susana Benet, Cristina Gálvez, et al. · Journal of Extracellular Vesicles · 22
PDF
Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?
2015 · Inma Jarrin, Nikos Pantazis, et al. · AIDS · 22
Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression
2014 · Judith Dalmau, Margalida Rotger, et al. · AIDS · 20
The Genome-wide Methylation Profile of CD4+ T Cells From Individuals With Human Immunodeficiency Virus (HIV) Identifies Distinct Patterns Associated With Disease Progression
2020 · Sara Moron-Lopez, Victor Urrea, et al. · Clinical Infectious Diseases · 19
PDF
Works count: 63
Citation count: 2,811
H-index: 22
I10-index: 35
Year
Topic
Type